Immediate Impact

32 standout
Sub-graph 1 of 14

Citing Papers

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
2024 Standout
2 intermediate papers

Works of Mathieu Puyade being referenced

Autologous Hematopoietic Stem Cell Transplantation for Behçet’s Disease: A Retrospective Survey of Patients Treated in Europe, on Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation
2021
Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer
2020

Author Peers

Author Last Decade Papers Cites
Mathieu Puyade 129 75 82 142 91 57 432
Kenneth W. Zamkoff 128 70 108 142 163 37 461
Bénédicte Deau 184 97 90 164 113 42 461
N.P. Lucie 78 92 161 117 76 43 506
Ho Jin Shin 100 50 115 131 88 45 446
Sadaya Matano 100 67 93 120 57 43 378
Bertrand Lioger 71 109 162 163 78 40 487
Xiaohui Zhao 101 46 77 120 68 33 422
Sumie Tabata 138 68 97 134 110 49 428
Richard A. Savage 93 93 169 113 67 29 450
Salvatore Buffardi 162 74 38 160 42 42 463

All Works

Loading papers...

Rankless by CCL
2026